Home / News / FAQ
FAQ

SenesTech Q2 2024 Financial Results Announcement FAQ

FaqStaq News - Just the FAQs • August 27, 2024
By FAQstaq Staff
Read Original Article →
SenesTech Q2 2024 Financial Results Announcement FAQ

Summary

SenesTech (NASDAQ: SNES) will host a conference call and webcast on Aug. 8, 2024, to discuss its Q2 2024 financial results, showcasing its leadership in fertility control for animal-pest management.

What is SenesTech announcing?

SenesTech is announcing a conference call and webcast to discuss its second quarter 2024 financial results, scheduled for Aug. 8, 2024, at 5 p.m. ET.

How can I access the SenesTech conference call?

You can access the call by dialing (844) 308-3351 or (412) 317-5407. A webcast will also be available at https://ibn.fm/TfQoW.

Will there be a replay of the conference call?

Yes, a replay of the call will be available on the company’s website for seven days, and a webcast replay will be available for 90 days. The replay can be accessed by dialing (877) 344-7529 or (412) 317-0088 with the replay access code 6578863.

What does SenesTech do?

SenesTech specializes in humane animal-pest population management through fertility control, offering products like ContraPest and Evolve, which are EPA-registered contraceptives for rodents.

Where can I find more information about SenesTech?

More information about SenesTech can be found on their website at www.SenesTech.com or in their newsroom at https://ibn.fm/SNES.

Why is SenesTech’s work significant?

SenesTech’s work is significant because it provides a humane, effective, and sustainable solution to managing animal-pest populations, aligning with the goals of clean cities, efficient businesses, and happy households.

What are the details for the webcast?

The webcast will be available at https://ibn.fm/TfQoW, and the full press release can be viewed at https://ibn.fm/eLF2C.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)

Article Control ID: 132313